Literature DB >> 21654471

Musculoskeletal manifestations of Sanfilippo Syndrome (mucopolysaccharidosis type III).

Klane K White1, Lori A Karol, Dustin R White, Susan Hale.   

Abstract

BACKGROUND: The most pronounced symptom in mucopolysaccharidosis type III (MPS III, Sanfilippo Syndrome) is the severe neurocognitive deterioration of the central nervous system. The effects of MPS III on the musculoskeletal system are less severe than those caused by other forms of MPS, however, it is our experience that many families seek orthopaedic attention for perceived musculoskeletal discomfort, particularly about the hip and spine. The purpose of this study is to report musculoskeletal findings in a case series of patients with MPS III.
METHODS: This study represents a retrospective case series of all records available from 2 institutions on patients with MPS III. Chart and radiographic review was performed and outcomes tabulated. Our hypotheses are: (1) Musculoskeletal abnormalities are prevalent in children with MPS III and (2) Musculoskeletal deformities in children with MPS III may require surgical intervention.
RESULTS: Eighteen patients were identified (10 female and 8 male) with an average age of 10.3 years. Three had significant scoliosis (21 to 99 degrees) and 2 others had L1 hypoplasia. Four patients had osteonecrosis of the femoral heads. One patient required a carpal tunnel release, and another a trigger thumb release. There were no cases of cervical instability.
CONCLUSIONS: In our study with these patients, we have observed several unreported musculoskeletal manifestations of MPS III. Osteonecrosis of the hips can be a source of severe discomfort for these children. Although uncommon, operative intervention for orthopaedic conditions is sometimes warranted. Operative indications in this cohort include progressive scoliosis of large magnitude, carpal tunnel syndrome, and trigger digits. LEVEL OF EVIDENCE: Level IV; case series.

Entities:  

Mesh:

Year:  2011        PMID: 21654471     DOI: 10.1097/BPO.0b013e31821f5ee9

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  17 in total

1.  The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.

Authors:  Elizabeth M Xing; Van W Knox; Patricia A O'Donnell; Tracey Sikura; Yuli Liu; Susan Wu; Margret L Casal; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

Review 2.  Spinal involvement in mucopolysaccharidoses: a review.

Authors:  Antonio Leone; Donato Rigante; Daniele Zaccaria Amato; Roberto Casale; Luigi Pedone; Nicola Magarelli; Cesare Colosimo
Journal:  Childs Nerv Syst       Date:  2014-10-31       Impact factor: 1.475

Review 3.  Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.

Authors:  Sun H Peck; Margret L Casal; Neil R Malhotra; Can Ficicioglu; Lachlan J Smith
Journal:  Mol Genet Metab       Date:  2016-06-04       Impact factor: 4.797

Review 4.  Mucopolysaccharidoses.

Authors:  Rolando Cimaz; Francesco La Torre
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

5.  Natural history of Sanfilippo syndrome in Spain.

Authors:  Verónica Delgadillo; Maria del Mar O'Callaghan; Laura Gort; Maria Josep Coll; Mercedes Pineda
Journal:  Orphanet J Rare Dis       Date:  2013-12-06       Impact factor: 4.123

6.  Recommendations on clinical trial design for treatment of Mucopolysaccharidosis Type III.

Authors:  Arunabha Ghosh; Elsa Shapiro; Stewart Rust; Kathleen Delaney; Samantha Parker; Adam J Shaywitz; Adelaida Morte; Gillian Bubb; Maureen Cleary; Tien Bo; Christine Lavery; Brian W Bigger; Simon A Jones
Journal:  Orphanet J Rare Dis       Date:  2017-06-26       Impact factor: 4.123

Review 7.  Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder.

Authors:  Frits A Wijburg; Grzegorz Węgrzyn; Barbara K Burton; Anna Tylki-Szymańska
Journal:  Acta Paediatr       Date:  2013-02-06       Impact factor: 2.299

8.  Does orthopaedic surgery improve quality of life and function in patients with mucopolysaccharidoses?

Authors:  N Williams; D Challoumas; D M Eastwood
Journal:  J Child Orthop       Date:  2017-08-01       Impact factor: 1.548

Review 9.  Pain in Mucopolysaccharidoses: Analysis of the Problem and Possible Treatments.

Authors:  Sabrina Congedi; Marcello Orzalesi; Chiara Di Pede; Franca Benini
Journal:  Int J Mol Sci       Date:  2018-10-08       Impact factor: 5.923

Review 10.  Orthopaedic challenges for mucopolysaccharidoses.

Authors:  Andrea Borgo; Andrea Cossio; Denise Gallone; Francesca Vittoria; Marco Carbone
Journal:  Ital J Pediatr       Date:  2018-11-16       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.